Align Technology (ALGN) EBITDA Margin: History & Chart

Align Technology, Inc.(ALGN)

Medical - Devices · Tempe, AZ

$147.00-6.00 (-3.92%)

Delayed quote: Sep 15, 2026, 4:00 PM EDT

About Align Technology, Inc.

Align Technology, Inc. is a medical technology enterprise that develops, produces, and markets its leading products: Invisalign transparent dental aligners and iTero digital intraoral scanners, along with related services. These offerings serve a wide range of dental professionals, including orthodontists, general dentists, and those specializing in restorative and cosmetic dentistry. The company's operations are divided into two main business units: "Clear Aligner" and "Scanners and Services." The Clear Aligner segment offers a variety of solutions. Its comprehensive products include the full Invisalign treatment for teenage patients, designed to address complex orthodontic needs such as mandibular advancement, patient compliance tracking, and managing tooth eruption. It also features specialized Invisalign First Phase I and Phase 2 packages for younger children, typically aged seven to ten, who have mixed dentition (a combination of primary and permanent teeth). Beyond these, the segment provides non-comprehensive aligner options like Invisalign moderate, lite, express, and Invisalign Go. Additional non-case products include retention devices, fees for Invisalign training, and sales of ancillary items such as cleaning materials and adjustment tools used by dental practitioners during treatment. The Scanners and Services segment centers around the iTero scanner, a unified hardware platform offering various software applications for both restorative and orthodontic procedures. It supplies specialized restorative software to general dentists, prosthodontists, periodontists, and oral surgeons, as well as distinct software for orthodontists to manage digital patient records, perform diagnoses, and facilitate the fabrication of printed models and retainers. This segment also provides computer-aided design and manufacturing (CAD/CAM) services, along with supplementary products like disposable covers for the scanner wand and iTero models and dies. Furthermore, it includes third-party scanners and digital scan solutions, the Invisalign Outcome Simulator (a chair-side and cloud-based application for the iTero scanner), the Invisalign Progress Assessment tool, and TimeLapse technology, which enables clinicians to compare a patient's historical 3D scans against current data. Align Technology distributes its products worldwide, with a strong presence in the United States, Switzerland, and China. Founded in 1997, the company is headquartered in Tempe, Arizona.

Tempe, AZ

20,435 employees

www.aligntech.com

Healthcare / Medical - Devices

Sector: Healthcare
Industry: Medical - Devices
CEO: Joseph Hogan

View full financials

ALGN EBITDA Margin Metrics

EBITDA MARGIN

19.75%

EBITDA MARGIN AVG TTM

18.19%

EBITDA MARGIN AVG 3Y

19.87%

EBITDA MARGIN AVG 5Y

21.01%

EBITDA MARGIN AVG 10Y

22.99%

EBITDA MARGIN AVG 15Y

23.63%

EBITDA MARGIN AVG 20Y

21.91%

CURRENT VS TTM AVG

+8.57%

CURRENT VS 3Y AVG

-0.62%

CURRENT VS 5Y AVG

-6.01%

CURRENT VS 10Y AVG

-14.10%

CURRENT VS 15Y AVG

-16.43%

CURRENT VS 20Y AVG

-9.87%

NAME	MARKET CAP	EBITDA MARGIN	TTM	3Y	5Y
Align Technology, Inc. (ALGN)	$10.53B	19.75%	18.19%	19.87%	21.01%
The Cooper Companies, Inc. (COO)vs ›	$10.39B	27.02%	27.38%	26.41%	26.36%
Universal Health Services, Inc. (UHS)vs ›	$10.71B	15.05%	14.69%	13.35%	14.10%
Molina Healthcare, Inc. (MOH)vs ›	$10.80B	2.15%	3.41%	4.20%	4.49%
Bio-Rad Laboratories, Inc. (BIO)vs ›	$10.17B	18.42%	17.41%	19.12%	20.05%
Globus Medical, Inc. (GMED)vs ›	$10.07B	20.41%	18.54%	20.94%	21.85%
The Ensign Group, Inc. (ENSG)vs ›	$10.07B	10.47%	10.43%	10.38%	10.85%
Henry Schein, Inc. (HSIC)vs ›	$9.97B	8.11%	8.11%	8.28%	8.19%
Bio-Techne Corporation (TECH)vs ›	$11.33B	28.74%	23.07%	27.33%	30.04%
Insulet Corp. (PODD)vs ›	$9.64B	21.67%	20.24%	16.36%	15.66%

NAME

MARKET CAP

EBITDA MARGIN

TTM

Align Technology, Inc. (ALGN)

$10.53B

19.75%

18.19%

19.87%

21.01%

The Cooper Companies, Inc. (COO)vs ›

$10.39B

27.02%

27.38%

26.41%

26.36%

Universal Health Services, Inc. (UHS)vs ›

$10.71B

15.05%

14.69%

13.35%

14.10%

Molina Healthcare, Inc. (MOH)vs ›

$10.80B

2.15%

3.41%

4.20%

4.49%

Bio-Rad Laboratories, Inc. (BIO)vs ›

$10.17B

18.42%

17.41%

19.12%

20.05%

Globus Medical, Inc. (GMED)vs ›

$10.07B

20.41%

18.54%

20.94%

21.85%

The Ensign Group, Inc. (ENSG)vs ›

$10.07B

10.47%

10.43%

10.38%

10.85%

Henry Schein, Inc. (HSIC)vs ›

$9.97B

8.11%

8.28%

8.19%

Bio-Techne Corporation (TECH)vs ›

$11.33B

28.74%

23.07%

27.33%

30.04%

Insulet Corp. (PODD)vs ›

$9.64B

21.67%

20.24%

16.36%

15.66%

EBITDA Margin FAQ

What is the EBITDA margin for Align Technology, Inc. (ALGN)?

The EBITDA margin for ALGN stock is 19.75%.

Is Align Technology, Inc.'s EBITDA margin high or low?

The EBITDA margin of 19.75% is in line with its 5-year average of 21.01%, around the middle of its 5-year range (8.57%–29.16%).

What is the TTM average EBITDA margin for Align Technology, Inc. (ALGN)?

The TTM average EBITDA margin for ALGN stock is 18.19%.

What is the 3Y average EBITDA margin for Align Technology, Inc. (ALGN)?

The 3Y average EBITDA margin for ALGN stock is 19.87%.

What is the 5Y average EBITDA margin for Align Technology, Inc. (ALGN)?

The 5Y average EBITDA margin for ALGN stock is 21.01%.

What is the 10Y average EBITDA margin for Align Technology, Inc. (ALGN)?

The 10Y average EBITDA margin for ALGN stock is 22.99%.

What is the 15Y average EBITDA margin for Align Technology, Inc. (ALGN)?

The 15Y average EBITDA margin for ALGN stock is 23.63%.

What is the 20Y average EBITDA margin for Align Technology, Inc. (ALGN)?

The 20Y average EBITDA margin for ALGN stock is 21.91%.

DATE	EBITDA MARGIN
2026-06-30	8.57%
2026-03-31	22.04%
2025-12-31	24.97%
2025-09-30	15.27%
2025-06-30	20.11%
2025-03-31	17.39%
2024-12-31	18.32%
2024-09-30	20.46%
2024-06-30	17.81%
2024-03-31	18.76%
2023-12-31	21.46%
2023-09-30	21.18%
2023-06-30	20.73%
2023-03-31	17.95%
2022-12-31	16.23%
2022-09-30	19.75%
2022-06-30	22.53%
2022-03-31	23.40%
2021-12-31	24.29%
2021-09-30	28.43%
2021-06-30	29.16%
2021-03-31	28.06%
2020-12-31	28.51%
2020-09-30	27.45%
2020-06-30	-14.04%
2020-03-31	16.45%
2019-12-31	26.62%
2019-09-30	24.18%
2019-06-30	32.57%
2019-03-31	19.31%
2018-12-31	25.66%
2018-09-30	27.57%
2018-06-30	27.60%
2018-03-31	25.09%
2017-12-31	28.63%
2017-09-30	28.22%
2017-06-30	25.93%
2017-03-31	22.41%
2016-12-31	25.78%
2016-09-30	24.76%
2016-06-30	26.07%
2016-03-31	24.35%
2015-12-31	27.88%
2015-09-30	20.49%
2015-06-30	22.27%
2015-03-31	26.87%
2014-12-31	28.14%
2014-09-30	29.43%
2014-06-30	27.57%
2014-03-31	25.79%
2013-12-31	32.03%
2013-09-30	27.55%
2013-06-30	25.48%
2013-03-31	-21.57%
2012-12-31	15.64%
2012-09-30	6.52%
2012-06-30	27.65%
2012-03-31	23.62%
2011-12-31	23.89%
2011-09-30	24.73%
2011-06-30	17.65%
2011-03-31	23.56%
2010-12-31	18.66%
2010-09-30	26.43%
2010-06-30	45.34%
2010-03-31	27.02%
2009-12-31	20.74%
2009-09-30	-69.37%
2009-06-30	12.43%
2009-03-31	12.02%
2008-12-31	6.24%
2008-09-30	11.92%
2008-06-30	8.80%
2008-03-31	10.28%
2007-12-31	11.11%
2007-09-30	16.42%
2007-06-30	22.26%
2007-03-31	16.31%
2006-12-31	-26.92%
2006-09-30	-17.73%
2006-06-30	-1.44%
2006-03-31	-6.02%
2005-12-31	6.53%
2005-09-30	1.39%
2005-06-30	7.29%
2005-03-31	9.61%
2004-12-31	19.96%
2004-09-30	13.39%
2004-06-30	14.72%
2004-03-31	7.91%
2003-12-31	14.33%
2003-09-30	10.61%
2003-06-30	4.49%
2003-03-31	-35.61%
2002-12-31	-33.93%
2002-09-30	-57.27%

DATE

EBITDA MARGIN

2026-06-30

8.57%

2026-03-31

22.04%

2025-12-31

24.97%

2025-09-30

15.27%

2025-06-30

20.11%

2025-03-31

17.39%

2024-12-31

18.32%

2024-09-30

20.46%

2024-06-30

17.81%

2024-03-31

18.76%

2023-12-31

21.46%

2023-09-30

21.18%

2023-06-30

20.73%

2023-03-31

17.95%

2022-12-31

16.23%

2022-09-30

19.75%

2022-06-30

22.53%

2022-03-31

23.40%

2021-12-31

24.29%

2021-09-30

28.43%

2021-06-30

29.16%

2021-03-31

28.06%

2020-12-31

28.51%

2020-09-30

27.45%

2020-06-30

-14.04%

2020-03-31

16.45%

2019-12-31

26.62%

2019-09-30

24.18%

2019-06-30

32.57%

2019-03-31

19.31%

2018-12-31

25.66%

2018-09-30

27.57%

2018-06-30

27.60%

2018-03-31

25.09%

2017-12-31

28.63%

2017-09-30

28.22%

2017-06-30

25.93%

2017-03-31

22.41%

2016-12-31

25.78%

2016-09-30

24.76%

2016-06-30

26.07%

2016-03-31

24.35%

2015-12-31

27.88%

2015-09-30

20.49%

2015-06-30

22.27%

2015-03-31

26.87%

2014-12-31

28.14%

2014-09-30

29.43%

2014-06-30

27.57%

2014-03-31

25.79%

2013-12-31

32.03%

2013-09-30

27.55%

2013-06-30

25.48%

2013-03-31

-21.57%

2012-12-31

15.64%

2012-09-30

6.52%

2012-06-30

27.65%

2012-03-31

23.62%

2011-12-31

23.89%

2011-09-30

24.73%

2011-06-30

17.65%

2011-03-31

23.56%

2010-12-31

18.66%

2010-09-30

26.43%

2010-06-30

45.34%

2010-03-31

27.02%

2009-12-31

20.74%

2009-09-30

-69.37%

2009-06-30

12.43%

2009-03-31

12.02%

2008-12-31

6.24%

2008-09-30

11.92%

2008-06-30

8.80%

2008-03-31

10.28%

2007-12-31

11.11%

2007-09-30

16.42%

2007-06-30

22.26%

2007-03-31

16.31%

2006-12-31

-26.92%

2006-09-30

-17.73%

2006-06-30

-1.44%

2006-03-31

-6.02%

2005-12-31

6.53%

2005-09-30

1.39%

2005-06-30

7.29%

2005-03-31

9.61%

2004-12-31

19.96%

2004-09-30

13.39%

2004-06-30

14.72%

2004-03-31

7.91%

2003-12-31

14.33%

2003-09-30

10.61%

2003-06-30

4.49%

2003-03-31

-35.61%

2002-12-31

-33.93%

2002-09-30

-57.27%

EBITDA Margin: 19.75%

ALGN EBITDA Margin

ALGN Average EBITDA Margin Chart

ALGN Current vs Average EBITDA Margin Chart

ALGN EBITDA Margin Metrics

ALGN Competitors' EBITDA Margin

Margin Comparison

EBITDA Margin Formula & Definition

EBITDA Margin FAQ

ALGN EBITDA Margin History

Related Metrics